Navigation Links
InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Date:3/15/2013

t, MGuard EPS may hold the potential to lower the incidence of adverse events and prolong survival of heart attack victims. The new InspireMD Carotid EPS stent will be available in a matrix of sizes ranging from small diameters of 5x20mm to large diameters up to 10x60mm for large carotid arteries.

Commenting on today's approvals, InspireMD's President and CEO, Alan Milinazzo , commented, "The CE mark approval for our MGuard carotid system is a major milestone for the Company and is further validation of  the Micronet technology. We look forward to accelerating our clinical development program with our carotid system. The CE mark should enhance our partnership strategy in the near term."

About InspireMD's EPS Technology

In stroke and acute heart attack patients, the plaque or thrombus is unstable and often breaks up as the stent is implanted causing downstream blockages (some of which can be fatal) in a significant portion of heart attack patients.

The InspireMD EPS stent system technology is integrated with a precisely engineered micro net mesh that prevents the unstable arterial plaque and thrombus (clots) that caused the blockage from breaking off.  The embolic protection is comprised of an ultra-thin polymer micron net that is integrated with the stent. The mesh is designed to provide outstanding and lifelong embolic protection, without affecting deliverability. MGuard EPS is CE Mark approved. InspireMD's Coronary EPS is now CE Mark approved. MGuard™ is not approved for sale in the U.S. by the U.S. Food and Drug Administration.

About InspireMD, Inc.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the OTC under the ticker sy
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
2. InspireMD Reports Results for Period Ended Dec. 31, 2012
3. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
4. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
5. InspireMD Reports Results For Period Ending Sept. 30, 2012
6. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
7. InspireMD to Present at Harvard Investors Group on June 27 in New York
8. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
9. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
10. InspireMD Announces First Quarter 2012 Financial Results
11. Cardium Receives ISO Certification for Excellagen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the widespread ... Michigan will offer free diagnostic testing for ... to administer tests and, in some cases, fill the matching ... the study. The Grand Rapids, Mich. ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Stryker Corporation (NYSE: SYK ) announced ... of Porex Corporation. Porex Surgical is a developer, manufacturer ... use primarily in reconstructive surgery of the head and ... market with strong brand recognition and considerable clinical data ...
... Pursuant to the provisions of Section 7 paragraph 1(a) ... Biedingen Wft) requiring a public announcement within four weeks following ... status update, Johnson & Johnson (NYSE: JNJ ) ... Swiss Exchange: CRX) provide the following joint update. ...
Cached Medicine Technology:Stryker Announces Acquisition of Privately-Held Porex Surgical 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 2Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 3Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 4Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer 5
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... Biology and Medicine a multidisciplinary research team ... in the Institute of Genomic Biology (IGB) on ... describe their recent work on subcellular redox homeostasis. ... functions including energy metabolism, signaling, and transcriptional processes. ... cellular behavior, redox status has been recognized as ...
(Date:4/17/2014)... In a review published in the April issue ... of The Feinstein Institute for Medical Research, says it,s ... community,s approach to treating sepsis, which kills ... , Sepsis occurs when molecules released into the bloodstream ... the body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2
... food and fluids during labour does not provide any ... University Associate Professor., "Based on our review, there is ... fluids, and perhaps food, for women during labour. ... Dr. Joan Tranmer of the Queen,s School of ...
... English-speaking Hispanic moms spend more time in front of ... News) -- Young children of Hispanic mothers whose main ... Hispanic moms who speak mostly English, a U.S. study ... 1,332 Hispanic and white mothers with children aged 4 ...
... ... system, Applicant Tracking System and Screening services. , ... Citrus Heights, CA (PRWEB) February 2, 2010 -- HR ... and efficient HRIS system, a web-based paperless Applicant Tracking System and an accurate, timely ...
... , MOUNT LAUREL, N.J. , Feb. 2 ... to announce the opportunity for individuals interested in voluntary service ... manager certification program in the United States . ... credential, CCMC is dedicated to upholding rigorous standards for its ...
... , Feb 2 The following news advisory was ...   Thirty-two Clear Channel stations nationwide will hold local radiothons ... , one of the world,s premier centers for the research and ... most organizations, St. Jude has not been immune to the effects ...
... might not be accurately diagnosed, Patients who do not have ... work, Calls for a briefer definition of the DSM-IV criteria ... led by Mark Zimmerman, MD, of Rhode Island Hospital indicates ... of psychiatrists reported that they often do not use the ...
Cached Medicine News:Health News:Spanish-Speaking Mothers Less Likely to Turn on TV 2Health News:HR Allen Provides Businesses with Three New Services. 2Health News:HR Allen Provides Businesses with Three New Services. 3Health News:CCMC Accepting Applications for Voluntary Service on its Board of Commissioners 2Health News:CCMC Accepting Applications for Voluntary Service on its Board of Commissioners 3Health News:32 Clear Channel Radio Stations Nationwide Unite to Fight Childhood Cancer February 11-12 2Health News:Study: Many physicians not using established criteria 2Health News:Study: Many physicians not using established criteria 3
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
... Reliance mobile surgical stretcher. M-701 ... of 24 in. to 32 in., ... You may specify a high range, ... A 4 in. pad can be ...
... Visionblue is a staining solution for ... required for performing a safe phaco-emulsification ... lens capsule may result in an ... risk of radial capsule tears and ...
Medicine Products: